315 related articles for article (PubMed ID: 16772340)
1. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women.
Lee DH; Silventoinen K; Hu G; Jacobs DR; Jousilahti P; Sundvall J; Tuomilehto J
Eur Heart J; 2006 Sep; 27(18):2170-6. PubMed ID: 16772340
[TBL] [Abstract][Full Text] [Related]
2. Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population.
Meisinger C; Löwel H; Heier M; Schneider A; Thorand B;
J Intern Med; 2005 Dec; 258(6):527-35. PubMed ID: 16313476
[TBL] [Abstract][Full Text] [Related]
3. Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes.
Bidel S; Silventoinen K; Hu G; Lee DH; Kaprio J; Tuomilehto J
Eur J Clin Nutr; 2008 Feb; 62(2):178-85. PubMed ID: 17342160
[TBL] [Abstract][Full Text] [Related]
4. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults.
Ruttmann E; Brant LJ; Concin H; Diem G; Rapp K; Ulmer H;
Circulation; 2005 Oct; 112(14):2130-7. PubMed ID: 16186419
[TBL] [Abstract][Full Text] [Related]
5. Stronger symptoms of depression predict high coronary heart disease mortality in older men and women.
Ahto M; Isoaho R; Puolijoki H; Vahlberg T; Kivelä SL
Int J Geriatr Psychiatry; 2007 Aug; 22(8):757-63. PubMed ID: 17133654
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction.
Emdin M; Passino C; Michelassi C; Titta F; L'abbate A; Donato L; Pompella A; Paolicchi A
Eur Heart J; 2001 Oct; 22(19):1802-7. PubMed ID: 11549302
[TBL] [Abstract][Full Text] [Related]
7. Serum γ-glutamyltransferase and the risk of heart failure in men and women in Finland.
Wang Y; Tuomilehto J; Jousilahti P; Salomaa V; Li B; Antikainen R; Mähönen M; Katzmarzyk PT; Hu G
Heart; 2013 Feb; 99(3):163-7. PubMed ID: 23144292
[TBL] [Abstract][Full Text] [Related]
8. Alcohol consumption and its contribution to the burden of coronary heart disease in middle-aged and older New Zealanders: a population-based case-control study.
Wells S; Broad J; Jackson R
N Z Med J; 2004 Mar; 117(1190):U793. PubMed ID: 15107896
[TBL] [Abstract][Full Text] [Related]
9. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.
Onat A; Can G; Örnek E; Çiçek G; Ayhan E; Doğan Y
Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402
[TBL] [Abstract][Full Text] [Related]
10. Primary risk factors influence risk of recurrent myocardial infarction/death from coronary heart disease: results from the Stockholm Heart Epidemiology Program (SHEEP).
Leander K; Wiman B; Hallqvist J; Andersson T; Ahlbom A; de Faire U
Eur J Cardiovasc Prev Rehabil; 2007 Aug; 14(4):532-7. PubMed ID: 17667644
[TBL] [Abstract][Full Text] [Related]
11. [Association between gamma-glutamyltransferase and hypertension incidence in rural prehypertensive adults].
Hwang JH; Shin JY; Chun By; Lee DH; Kim KY; Park WH; Chae Sc
J Prev Med Public Health; 2010 Jan; 43(1):18-25. PubMed ID: 20185979
[TBL] [Abstract][Full Text] [Related]
12. The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease.
Hu G; Jousilahti P; Qiao Q; Peltonen M; Katoh S; Tuomilehto J
J Am Coll Cardiol; 2005 May; 45(9):1413-8. PubMed ID: 15862411
[TBL] [Abstract][Full Text] [Related]
13. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women.
Juutilainen A; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
Diabetes Care; 2007 Feb; 30(2):292-9. PubMed ID: 17259497
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and prognostic significance of elevated gamma-glutamyltransferase in chronic heart failure.
Poelzl G; Eberl C; Achrainer H; Doerler J; Pachinger O; Frick M; Ulmer H
Circ Heart Fail; 2009 Jul; 2(4):294-302. PubMed ID: 19808352
[TBL] [Abstract][Full Text] [Related]
15. Joint effects of history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease.
Hu G; Jousilahti P; Tuomilehto J
Eur Heart J; 2007 Dec; 28(24):3059-66. PubMed ID: 17981826
[TBL] [Abstract][Full Text] [Related]
16. The diabetes-cardiovascular risk paradox: results from a Finnish population-based prospective study.
Barengo NC; Katoh S; Moltchanov V; Tajima N; Tuomilehto J
Eur Heart J; 2008 Aug; 29(15):1889-95. PubMed ID: 18559404
[TBL] [Abstract][Full Text] [Related]
17. Alcohol consumption and cardiovascular mortality accounting for possible misclassification of intake: 11-year follow-up of the Melbourne Collaborative Cohort Study.
Harriss LR; English DR; Hopper JL; Powles J; Simpson JA; O'Dea K; Giles GG; Tonkin AM
Addiction; 2007 Oct; 102(10):1574-85. PubMed ID: 17854334
[TBL] [Abstract][Full Text] [Related]
18. Association of gamma-glutamyltransferase with incidence of type 2 diabetes in Japan.
Fujita M; Ueno K; Hata A
Exp Biol Med (Maywood); 2010 Mar; 235(3):335-41. PubMed ID: 20404051
[TBL] [Abstract][Full Text] [Related]
19. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort.
André P; Balkau B; Vol S; Charles MA; Eschwège E;
Diabetes Care; 2007 Sep; 30(9):2355-61. PubMed ID: 17586745
[TBL] [Abstract][Full Text] [Related]
20. Is vigorous physical activity contraindicated in subjects with coronary heart disease? Evidence from the Caerphilly study.
Yu S; Patterson CC; Yarnell JW
Eur Heart J; 2008 Mar; 29(5):602-8. PubMed ID: 18245114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
